Anti-CTLA-4 antibody compositions

Details for Australian Patent Application No. 2006220829 (hide)

Owner Pharmacia & Upjohn Company LLC

Inventors Muthurania, Kevin Wamiti; Singh, Satish Kumar; Elliott, Carrie Marie; Abate, Justin Donald; Das, Tapan Kanti; Nema, Sandeep

Agent Allens Arthur Robinson

Pub. Number AU-B-2006220829

PCT Pub. Number WO2006/096491

Priority 60/659,766 08.03.05 US; 60/728,165 19.10.05 US; 60/762,456 26.01.06 US; 60/752,712 20.12.05 US

Filing date 2 March 2006

Wipo publication date 14 September 2006

Acceptance publication date 13 October 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/18 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

13 September 2007 PCT application entered the National Phase

  PCT publication WO2006/096491 Priority application(s): WO2006/096491

13 October 2011 Application Accepted

  Published as AU-B-2006220829

9 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006220835-Vaccines comprising oligonucleotides having immunostimulatory sequences (ISS) wherein the ISS are conjugated to antigens and stabilized by buffer conditions and further excipients

2006220828-Anti-MAdCAM antibody compositions